Myoview Injection, Powder, Lyophilized, For Solution
NDC Package 17156-024-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Myoview (tetrofosmin) injection is none. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Medi-physics Inc. Dba Ge Healthcare, this product is identified by NDC 17156-024 and is authorized under FDA application NDA020372.

Identification & Billing

NDC Package Code
17156-024-05
Package Description
5 VIAL in 1 KIT / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Product Code
17156-024
11-Digit Billing Format
17156002405
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
5 EA

Clinical Specifications

Proprietary Name
Myoview
Non-Proprietary Name
Tetrofosmin
Substance Name
Tetrofosmin
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
TETROFOSMIN .23 mg/1
Usage Information
None.

Regulatory & Marketing

Labeler Name
Medi-physics Inc. Dba Ge Healthcare
Product Type
Human Prescription Drug
FDA Application #
NDA020372
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-09-1996
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17156-024-05 identifies a specific commercial package of 5 vial in 1 kit / 1 injection, powder, lyophilized, for solution in 1 vial of Myoview, a human prescription drug labeled by Medi-physics Inc. Dba Ge Healthcare. This product is billed for "EA" each discreet unit and contains an estimated amount of 5 billable units per package. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains tetrofosmin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medi-physics Inc. Dba Ge Healthcare on February 09, 1996. The current certification is valid through December 31, 2026.

How is this Medi-physics Inc. Dba Ge Healthcare product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17156002405. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17156-024-05
11-Digit CMS (5-4-2)
17156-0024-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.